Join expert faculty for a 1-hour, interactive multimedia program with downloadable slides and an interactive case study and patient video. Learn about new recommendations and clinical evidence on the safety and efficacy of direct-acting oral anticoagulants (DOACs) in patients with obesity. This program is accompanied by 2 ClinicalThought commentaries by expert faculty on the topic of venous thromboembolism (VTE) management in patients with obesity, and a downloadable handout that can be shared with patients.
Coming Soon:
- ClinicalThought Expert Commentaries
Faculty
Christian T. Ruff, MD, MPH Associate Professor of MedicineHarvard Medical SchoolDirectorGeneral CardiologyCardiovascular DivisionBrigham and Women's HospitalBoston, Massachusetts
Daniel Thibodeau, DHSc, MHP, PA-C Physician Assistant ProgramDirector of Medical Science ProgramEastern Virginia Medical SchoolPhysician AssistantDivision of CardiologySentara Medical GroupSentara Health SystemsNorfolk, Virginia
Preventing Recurrent VTE in Persons with Obesity
- Clinical Thought
- Expiration Date: 5/08/23
- Not certified for credit.
Weighing in on Optimal Management of VTE in Patients With Obesity
- eCourse
- Expiration Date: 4/14/23
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
Weighing in on Optimal Management of VTE in Patients With Obesity
- PDF Resource
- Expiration Date: 4/14/23
- Not certified for credit.
Weighing in on Optimal Management of VTE in Patients With Obesity
- Downloadable Slideset
- Expiration Date: 4/14/23
- Not certified for credit.
Provided by Practicing Clinicians Exchange.
Supported by an educational grant from the Bristol-Myers Squibb and Pfizer Alliance; and Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
